SAN DIEGO--(BUSINESS WIRE)--Clarify Medical today announced that the Clarify Medical™ Home Phototherapy System - used to treat psoriasis, eczema and vitiligo - is available to health plan members who access MultiPlan’s PHCS and MultiPlan Networks, effective immediately. MultiPlan helps healthcare payer clients in the group health, government, and property and casualty markets manage the cost of care through solutions that combine its payment integrity, network-based and analytics-based services.
About the Clarify Medical Home Phototherapy System
Clarify Medical, an early commercial stage, venture-backed company, is scaling a revolutionary home light therapy platform used for the treatment of chronic skin conditions such as psoriasis, vitiligo, and eczema (affecting over 40 million people in the U.S.). As the first at-home, connected phototherapy treatment platform, Clarify empowers patients to better manage and self-deliver care.
Clarify vastly improves the treatment experience for patients with these skin conditions through a connected, handheld narrowband UVB phototherapy treatment device that automatically manages patient-specific dosing, frequency, and duration of therapy through a smartphone application and Clarify’s proprietary software. The Clarify platform enables all stakeholders to monitor treatment adherence, progress, patient satisfaction, and clinical outcomes. Patients receive “always on” care support by Clarify CarePartners, who guide patients to drive treatment adherence, improve efficacy, and enhance long-term health outcomes.
The platform, which is the first of its kind, has received FDA 510(k) clearance, ACHC accreditation, and is reimbursed by Medicare and a number of private insurance carriers.
About Clarify Medical, Inc.
Clarify Medical, based in San Diego, CA, is an early commercial stage, venture-backed digital health company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions. Its Clarify Medical™ Home Phototherapy System is now available nationally in the U.S. Learn more at www.clarifymed.com.
MultiPlan is committed to helping healthcare payers manage the cost of care, improve their competitiveness, and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, the company interprets clients’ needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payers in the commercial health, dental, government and property and casualty markets, and saves these companies more than $18 billion annually. MultiPlan is owned by Hellman & Friedman and other investors. For more information, visit multiplan.com.